Sarah – Interview 38
Sarah volunteered for a placebo-controlled trial of a drug intended to help women at risk of osteoporosis. It involved daily injections and eventually she dropped out of the trial. (You can see Sarah talking more about her experiences on the healthtalkonline site osteoporosis, Interview 27).
Sarah worked in a hospital and saw a notice asking for volunteers for a trial of a drug for osteoporosis in 2002. Volunteers needed to be women over 50 who were taking hormone replacement therapy and who thought they might be at risk of osteoporosis. As Sarah had broken several bones she thought this might apply to her so she volunteered. She had a body scan and was told she did indeed have osteoporosis and so was suitable for the trial.
Women involved in the trial were asked to inject themselves in the stomach but they would not know whether they were injecting the drug or a placebo. At first they had to do two injections a day but this was later reduced to one. Sarah stayed in the trial for several months despite it being quite unpleasant. However, she had a distressing period when a close relative had to spend time in hospital. She started to associate the smell of the hospital with the smell of the substance she had to inject, and felt she could not continue. The trial staff did not put her under any pressure to stay in the trial and understood her feelings. Sarah’s impression is that recruitment to the trial was not very good and other people had also dropped out, perhaps because it was a big thing to ask people to inject themselves daily.
Sarah assumed that her GP would be told that she had been diagnosed with osteoporosis. However, in 2008 (a few months before being interviewed) she broke two bones in her spine and discovered that her GP had never learnt of her diagnosis. Now she feels angry that she could have been taking medication all that time to try to stop the osteoporosis from getting worse if only her GP had known. She feels there could have been much better communication between the trial and her GP.
She has since volunteered for another trial of medication to control lipids as she has familial mixed hyperlipidaemia. After two weeks in the trial she was told she was not eligible after all, because they only wanted to include people who were already taking statins as part of their treatment. Despite these mixed experiences, Sarah would still volunteer again, because she believes research is the only way to improve medical treatments and find out what works. (You can see Sarah talking more about her experiences on the osteoporisis healthtalkonline site, Interview 27).